The Clorox Company (CLX)
SubavaliadaFundamental
53
Preço
$81.01
Capitalização de Mercado
$9.89B
Parte 1 · Quanto vale a empresa
Visão Geral
Clorox makes household staples sold under well-known names: bleach and cleaning sprays under its own Clorox brand, trash bags under Glad, charcoal under Kingsford, and personal-care and health products including Burt's Bees. It manufactures most of what it sells, ships it to large retailers, and relies on repeat, habitual purchases rather than one-off sales — a household restocks bleach or trash bags on a predictable cycle regardless of the wider economy.
Como gera receita
Revenue comes from selling packaged goods to a concentrated set of large retailers, who then resell to shoppers. Margins depend on the cost of raw materials such as resin and chemicals, on manufacturing efficiency, and on holding shelf space and brand loyalty against cheaper private-label alternatives that retailers sell alongside Clorox's own products. The company reports results across four segments split by product category and by U.S. versus international markets.
Receita por segmento
Cleaning and disinfecting products under Clorox, plus water filtration under Brita and vitamins under Natural Vitality.
Trash bags under Glad, cat litter under Fresh Step and Scoop Away, and charcoal under Kingsford.
Food products including Hidden Valley dressings, and personal care through Burt's Bees.
The same core product categories sold outside the United States, mainly in Latin America and Canada.
Vantagem competitiva
Marca · EstreitaNames like Clorox, Glad and Kingsford have been the default choice on U.S. shelves for generations, which lets the company hold shelf space and charge more than an unbranded equivalent. The advantage is narrow: retailer store brands compete directly in nearly every category, and a large retailer with real pricing leverage can push back hard on Clorox's terms.
O que impulsiona a procura
DefensivoCleaning products, trash bags and personal care items are routine, non-discretionary household purchases that people keep buying in a downturn, which makes volume relatively stable across the economic cycle. The bigger swings in results tend to come from input-cost inflation and from consumers trading down to private label when money is tight, not from skipping the purchase altogether.
Principais riscos
- Retailer concentration — With Walmart alone worth nearly 27% of net sales, large retailers have the leverage to demand better pricing terms or to favour their own private-label products over Clorox's brands.
- Input cost and supply chain disruption — Volatile commodity, packaging, labour, energy and logistics costs, along with the risk of supply disruption from conflicts such as those in Ukraine, the Middle East, or tensions between China and Taiwan, can raise costs faster than prices can be adjusted.
- Cybersecurity — The company depends heavily on information technology systems and has already suffered a major cyberattack, in August 2023, that disrupted operations; a repeat incident could again halt production and shipments.
- Private-label competition — Store-brand alternatives, often priced well below Clorox's products, compete in nearly every category the company sells in, forcing continued spending on marketing and innovation to defend market share.
Concentração de clientes
Os principais clientes representam 27% da receita
Walmart and its affiliates accounted for nearly 27% of net sales in fiscal 2025, giving a single retailer significant leverage over shelf placement, promotional terms and pricing.
Os argumentos a favor
Buyers argue that Clorox's brands are habit-forming staples that hold shelf space no private label can fully dislodge, and that the company's cost-savings programme and full recovery from the 2023 cyberattack position it to grow margins even on roughly flat sales.
Os argumentos contra
Sellers worry that with Walmart alone worth over a quarter of sales, Clorox has limited room to push back on retailer demands, and that persistent private-label competition plus input-cost inflation could keep squeezing volumes and margins at the same time.
Written by the editors, published on 18 de agosto de 2026
Direct competitors
Who this company fights with for the same customers
Generated on 18 de setembro de 2026 with claude-haiku-4-5 — shared with all users
Reckitt's Lysol is the closest rival to Clorox's core disinfecting bleach, sprays and wipes, fighting for the same shelf space and the same household and professional cleaning budgets in North America.
Church & Dwight sells Arm & Hammer cleaning and laundry additives, cat litter and personal care to the same value-minded U.S. grocery and mass-market shopper Clorox depends on.
P&G's Mr. Clean, Swiffer, Dawn and Febreze compete directly with Clorox's home-cleaning lines for the same retail shelf and promotional slots, backed by far larger advertising and R&D budgets.
Colgate-Palmolive's home-care brands — Fabuloso, Ajax, Murphy Oil Soap — target the same surface-cleaning customer in the United States and in Clorox's Latin American markets.
This privately held U.S. group competes across several Clorox aisles at once: Windex and Scrubbing Bubbles against Clorox cleaners, Ziploc against Glad bags and wraps, Glade against home fragrance.
Unilever competes with Clorox on two fronts: Domestos and Cif bleach and surface cleaners outside the U.S., and Dove, Vaseline and Simple against Burt's Bees in natural personal care.
Balanço & Liquidez
Receita
$6.76B
Últimos 12 meses (até 31/03/2026)
Resultado Líquido
$756M
Últimos 12 meses (até 31/03/2026)
Fluxo de Caixa Livre
$761M
Capital Próprio Total
$321M
Passivo Total
$5.08B
Rácio de Liquidez
0.84
Cobertura de Juros
-
Dívida/EBITDA
3.94
Resultados Por Ação
Receita & Resultado Líquido
Fluxo de Caixa Livre
Decomposição dos Resultados
Demonstração histórica
Margens ao longo do tempo
A dívida ao longo do tempo
Quanto pesa a dívida
Grelha do crescimento
Crescimento — Receitas
Estimativa de Valor Justo
Valor Justo
$108.06
Preço Atual
$81.01
Margem de Segurança
+25.0%
Intervalo de Valor Justo
$70.24 - $145.88
Dispersão entre os métodos de avaliação utilizados, não um intervalo de confiança calibrado estatisticamente.
Métodos de Estimativa
Métricas de Avaliação
Rácio P/E
13.15
ROE
252.3%
Rácio P/B
30.81
P/FCF
25.78
Margem Bruta
43.8%
ROIC
-
Radar de Rentabilidade
Criação de Valor (Vantagem Competitiva)
ROIC
-
WACC
6.0%
ROIC − WACC
-
Critérios de Análise Fundamental
Aprovado (12)
- EPS shows upward trend
- Gross Margin 43.8%
- P/FCF 25.78
- Positive Free Cash Flow
- Current Ratio
- Debt/EBITDA
- Return on Tangible Assets
- ROE 181.1%
- Earnings Quality (OCF/NI) 0.76
- Share Dilution -0.2%
- Net Margin Trend 11.2% vs 9.9%
- Piotroski F-Score 8/9
Reprovado (11)
- EPS CAGR 4.22%
- Price CAGR -3.51%
- P/B Ratio 30.81
- Debt/Equity ratio
- CapEx intensity
- Low reliance on intangibles
- Price below Graham Number
- DCF valuation (Fairly valued)
- Revenue Growth 5Y -1.8%
- Analyst Consensus 4% Buy
- Earnings Surprise avg 1.8%
Indisponível (5)
- ROIC NaN%
- Dividend Payout NaN%
- Operating Margin NaN%
- Interest Coverage
- PEG Ratio (need PE > 0 and growth > 0)
Piotroski F-Score
Saúde financeira sólida
Qualidade dos Resultados
Moderada: alguma diferença entre lucros e caixa
Diluição de Ações
A recomprar ações. Favorável ao acionista
Participações institucionais
Governação
Equipa Executiva
| Nome | Cargo | Idade |
|---|---|---|
| Ms. Linda J. Rendle | CEO & Chairman | 47 |
| Mr. Luc Bellet | Executive VP & CFO | 46 |
| Mr. Chris T. Hyder | Executive VP & COO | 50 |
| Ms. Nina Barton | Executive VP and Chief Growth & Strategy Officer | 51 |
| Ms. Laura E. Peck | VP, Chief Accounting Officer & Corporate Controller | 48 |
| Ms. Chau Banks | Senior VP and Chief Information & Data Officer | 56 |
| Ms. Kirsten M. Marriner | Executive VP & Chief Administrative Officer | 52 |
| Ms. Lisah Burhan | Vice President of Investor Relations | - |
| Ms. Angela C. Hilt | Executive VP, Chief Legal & External Affairs Officer and Corporate Secretary | 53 |
| Mr. Eric Sean Schwartz | Senior VP & Chief Marketing Officer | 53 |
Risco de Auditoria
7
Risco do Conselho
3
Risco de Remuneração
6
Risco dos Direitos dos Acionistas
8
Parte 2 · O preço e o momento de entrar
Esta parte não serve para saber se a empresa vale: serve para escolher quando comprá-la, depois que os fundamentos te convenceram. Dentro: análise técnica, potencial, quedas históricas, exposição gama.
Documentos
- Ver documento
Relatório anual (10-K)
Uma visão anual do negócio, dos resultados financeiros e dos riscos da empresa.
Arquivado em 2026-08-07
- Ver documento
Relatório trimestral (10-Q)
Uma atualização sobre o desempenho financeiro dos últimos três meses.
Arquivado em 2026-04-30
- Ver documento
Relatório de fato relevante (8-K)
Um aviso sobre um fato relevante, como uma mudança na liderança ou um grande anúncio.
Arquivado em 2026-08-03
via SEC EDGAR
Histórico de Resultados
via SEC EDGAR
Latest News
Recent headlines for CLX, sourced from Markets Gazette.
- 8/3/2026POSITIVEClorox Expects Full-Year Sales Boost From Purell Deal
The Clorox Company announced fiscal fourth-quarter earnings that surpassed analyst forecasts, signaling resilience despite challenges. While sales volumes were down and the recent acquisition of GOJO Industries, the maker of Purell, incurred additional logistics costs, the overall financial performance indicates effective management. The company anticipates a full-year sales boost stemming from the Purell integration, suggesting a positive outlook for future revenue streams. Investors will be watching the successful integration of GOJO and its impact on Clorox's market position and profitability in the coming quarters.
via Markets Gazette